About me
Founder of Apath Nexus, Lindsay provides strategic regulatory guidance and intelligence to support innovation and compliance with FDA and select international frameworks. He has worked with pharmaceutical and biotechnology companies, patient groups, and trade associations to align regulatory strategy with business and policy goals. As a Regulatory Commentator, he translates evolving FDA policy, early regulatory signals, and competitor activity into actionable insights. His speaking roles include moderating expert panels and presenting on topics such as Accelerated Approval, regulatory flexibility, policy trends shaping drug development, and the role of regulatory intelligence in strategic planning.
